Hydrogen Sulfide Alleviates Lipopolysaccharide-Induced Diaphragm Dysfunction in Rats by Reducing Apoptosis and Inflammation through ROS/MAPK and TLR4/NF-κB Signaling Pathways. (24th May 2018)

• Record Type: Journal Article
• Authors: Zhang, Guo-Yu; Lu, Dan; Duan, Shao-Feng; Gao, Ying-Ran; Liu, Shi-Yu; Hong, Ya; Dong, Peng-Zhen; Chen, Ya-Ge; Li, Tao; Wang, Da-Yong; Cheng, Xiang-Shu; He, Fei; Wei, Jian-She; Li, Guang-Yu; Zhang, Qing-Yong; Wu, Dong-Dong; Ji, Xin-Ying
• Other Names: Kelley Eric E. Academic Editor.
• Is Part Of: Oxidative medicine and cellular longevity. Volume 2018(2018)
• Publication Date: 2018-05-24
• Subjects: Oxidative stress -- Periodicals; Cells -- Aging -- Periodicals; Cells -- Aging; Oxidative stress; Oxidative Stress -- Periodicals; Cell Aging -- Periodicals; Periodicals; 611.0181
• DOI: 10.1155/2018/9647809
• Languages: English
• ISSNs: 1942-0900

Abstract

Abstract : Diaphragm dysfunction is an important clinical problem worldwide. Hydrogen sulfide (H2 S) is involved in many physiological and pathological processes in mammals. However, the effect and mechanism of H2 S in diaphragm dysfunction have not been fully elucidated. In this study, we detected that the level of H2 S was decreased in lipopolysaccharide- (LPS-) treated L6 cells. Treatment with H2 S increased the proliferation and viability of LPS-treated L6 cells. We found that H2 S decreased reactive oxygen species- (ROS-) induced apoptosis through the mitogen-activated protein kinase (MAPK) signaling pathway in LPS-treated L6 cells. Administration of H2 S alleviated LPS-induced inflammation by mediating the toll-like receptor-4 (TLR-4)/nuclear factor-kappa B (NF- κ B) signaling pathway in L6 cells. Furthermore, H2 S improved diaphragmatic function and structure through the reduction of inflammation and apoptosis in the diaphragm of septic rats. In conclusion, these findings indicate that H2 S ameliorates LPS-induced diaphragm dysfunction in rats by reducing apoptosis and inflammation through ROS/MAPK and TLR4/NF- κ B signaling pathways. Novel slow-releasing H2 S donors can be designed and applied for the treatment of diaphragm dysfunction.